Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose

por Ilaria Vicenti, Monica Basso, Francesca Gatti, Renzo Scaggiante, Adele Boccuto, Daniela Zago, Eliana Modolo, Filippo Dragoni, Saverio Giuseppe Parisi, Maurizio Zazzi
Publicado 2021

Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study

por Rana Shibli, Ofra Barnett, Zomoroda Abu-Full, Naomi Gronich, Ronza Najjar-Debbiny, Ilana Doweck, Gad Rennert, Walid Saliba
Publicado 2021